FindTrial
Sign In

Establishment and application of prediction model for prognosis of AIDS complicated with disseminated nontuberculous mycosis based on IFN - gamma autoantibody

Establishment and application of prediction model for prognosis of AIDS complicated with disseminated nontuberculous mycosis based on IFN - gamma autoantibody

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036892
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

AIDS

Interventions

Gold Standard:Clinical outcome
Index test:IFN-gamma&#32
concentration

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with AIDS and disseminated NTM disease. The basis for confirmation is: HIV-1 / 2 antibody test positive (including screening test and confirmation test) or HIV isolation test or two times of HIV nucleic acid test positive; blood, lymph tissue, or bone marrow culture Mycobacterium positive. 2. The serum IFN - ? antibody was positive.

Exclusion criteria

Exclusion criteria: Exclusion criteria: patients could not strictly follow the doctor's advice and follow-up requirements.

Design outcomes

Primary

MeasureTime frame
IFN-gamma antibody;ACC, SEN, SPE, AUC of ROC;—

Countries

China

Contacts

Public ContactLI LIU

Shanghai Public Health Clinical Center

liuli@shphc.org.cn+86 18916091026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026